FVSKX
Price
$50.06
Change
+$0.14 (+0.28%)
Updated
May 9 closing price
Net Assets
1.67B
MVCAX
Price
$29.44
Change
-$0.01 (-0.03%)
Updated
May 9 closing price
Net Assets
16.47B
Ad is loading...

FVSKX vs MVCAX

Header iconFVSKX vs MVCAX Comparison
Open Charts FVSKX vs MVCAXBanner chart's image
Fidelity Value Strategies K
Price$50.06
Change+$0.14 (+0.28%)
VolumeN/A
Net Assets1.67B
MFS Mid Cap Value A
Price$29.44
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets16.47B
FVSKX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FVSKX vs. MVCAX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVSKX is a Buy and MVCAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.5B vs. FVSKX (1.67B). MVCAX pays higher dividends than FVSKX: MVCAX (0.93) vs FVSKX (0.37). FVSKX was incepted earlier than MVCAX: FVSKX (17 years) vs MVCAX (24 years). MVCAX (1.00) is less costly to investors than FVSKX (0.72). FVSKX is a more actively managed with annual turnover of: 61.00 vs. MVCAX (27.00). FVSKX has a lower initial minimum investment than MVCAX: FVSKX (0) vs MVCAX (1000). MVCAX annual gain was more profitable for investors over the last year : -8.00 vs. FVSKX (-14.57). FVSKX return over 5 years is better than : 77.13 vs. MVCAX (58.65).
FVSKXMVCAXFVSKX / MVCAX
Total Expense Ratio0.720.9973%
Annual Report Gross Expense Ratio0.721.0072%
Fund Existence17 years24 years-
Gain YTD-9.054-4.009226%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.67B16.5B10%
Annual Yield % from dividends0.370.9340%
Returns for 1 year-14.57-8.00182%
Returns for 3 years6.076.2497%
Returns for 5 years77.1358.65132%
Returns for 10 years13.6051.6626%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TFC39.01-0.03
-0.08%
Truist Financial Corp
JHG36.36-0.10
-0.27%
Janus Henderson Group plc
SPRY13.44-0.05
-0.37%
ARS Pharmaceuticals
RYAM3.63-0.13
-3.46%
Rayonier Advanced Materials
AKTX1.26-0.08
-5.96%
Akari Therapeutics plc